Seed Jennifer, Carney Edward W, Corley Richard A, Crofton Kevin M, DeSesso John M, Foster Paul M D, Kavlock Robert, Kimmel Gary, Klaunig James, Meek M E, Preston R Julian, Slikker William, Tabacova Sonia, Williams Gary M, Wiltse Jeanette, Zoeller R Thomas, Fenner-Crisp Penelope, Patton Dorothy E
US Environmental Protection Agency, Washington, DC, USA.
Crit Rev Toxicol. 2005 Oct-Nov;35(8-9):664-72. doi: 10.1080/10408440591007133.
A complete mode of action human relevance analysis--as distinct from mode of action (MOA) analysis alone--depends on robust information on the animal MOA, as well as systematic comparison of the animal data with corresponding information from humans. In November 2003, the International Life Sciences Institute's Risk Science Institute (ILSI RSI) published a 2-year study using animal and human MOA information to generate a four-part Human Relevance Framework (HRF) for systematic and transparent analysis of MOA data and information. Based mainly on non-DNA-reactive carcinogens, the HRF features a "concordance" analysis of MOA information from both animal and human sources, with a focus on determining the appropriate role for each MOA data set in human risk assessment. With MOA information increasingly available for risk assessment purposes, this article illustrates the further applicability of the HRF for reproductive, developmental, neurologic, and renal endpoints, as well as cancer. Based on qualitative and quantitative MOA considerations, the MOA/human relevance analysis also contributes to identifying data needs and issues essential for the dose-response and exposure assessment steps in the overall risk assessment.
完整的作用模式人体相关性分析(与单纯的作用模式分析不同)依赖于有关动物作用模式的可靠信息,以及将动物数据与来自人类的相应信息进行系统比较。2003年11月,国际生命科学研究所风险科学研究所(ILSI RSI)发表了一项为期两年的研究,该研究利用动物和人类作用模式信息生成了一个四部分的人体相关性框架(HRF),用于对作用模式数据和信息进行系统且透明的分析。HRF主要基于非DNA反应性致癌物,其特点是对来自动物和人类的作用模式信息进行“一致性”分析,重点在于确定每个作用模式数据集在人体风险评估中的适当作用。随着越来越多的作用模式信息可用于风险评估目的,本文阐述了HRF在生殖、发育、神经和肾脏终点以及癌症方面的进一步适用性。基于定性和定量的作用模式考量,作用模式/人体相关性分析也有助于确定总体风险评估中剂量反应和暴露评估步骤所需的数据及关键问题。